Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients

References

• Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 1996;94:1528–36.
   PubMed Web of Science ®Google Scholar
• Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, . Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241–51.
   PubMed Web of Science ®Google Scholar
• Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ. Death following creatine kinase-MB elevation after coronary intervention:Identification of an early risk period:Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation. 2002;106:1205–10.
   PubMed Web of Science ®Google Scholar
• Akkerhuis KM, Alexander JH, Tardiff BE, Boersma E, Harrington RA, Lincoff AM, . Minor myocardial damage and prognosis:Are spontaneous and percutaneous coronary intervention-related events different? Circulation. 2002;105:554–6.
   PubMed Web of Science ®Google Scholar
• Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, . Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J. 2004;25:313–21.
   PubMed Web of Science ®Google Scholar
• Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutanous or surgical revascularisation and three-year mortality. J Am Coll Cardiol. 2002;40:1961–7.
   PubMed Web of Science ®Google Scholar
• Ionnidis JPA, Karvouni E, Katritsis D. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1406–11.
   PubMed Web of Science ®Google Scholar
• Herrmann J. Peri-procedural myocardial injury:update. Eur Heart J. 2005;26:2493–519.
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, . Clinical end points in coronary stent trials:A case for standardized definitions. Circulation. 2007;115:2344–51.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525–38.
   PubMed Web of Science ®Google Scholar
• The joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined–A consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36: 959–69. doi:10.1016/S0735-10970000804-4.
   PubMed Web of Science ®Google Scholar
• Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code manual of electrocardiographic findings. Bristol:John Wright ;1982.
   Google Scholar
• Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. New Eng J Med. 1997;337:230–6.
   PubMed Web of Science ®Google Scholar
• Vikenes K, Andersen KA, Farstad M, Nordrehaug JE. Temporal pattern of cardiac troponin I after thoracotomy and lung surgery. Int J Cardiol. 2004;96:403–7.
   PubMed Web of Science ®Google Scholar
• Hodakowski GT, Craver JM, Jones EL, King SB 3rd, Guyton RA. Clinical significance of perioperative Q-wave myocardial infarction:The Emory Angioplasty versus Surgery Trial. J Thorac Cardiovasc Surg. 1996;112:1447–53.
   PubMed Web of Science ®Google Scholar
• Adams JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, . Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993;88:101–6.
   Google Scholar
• Ahmed SA, Williamson JR, Roberts R, Clark RE, Sobel BE. The association of increased plasma MB CPK activity and irreversible ischemic myocardial injury in the dog. Circulation. 1976;54:187–93.
   PubMed Web of Science ®Google Scholar
• Feng YJ, Chen C, Fallon JT, Lai T, Chen L, Knibbs DR, . Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model. Am J Clin Pathol. 1998;110:70–7.
   PubMed Web of Science ®Google Scholar
• Piper HM, Schwartz P, Spahr R, Spieckermann PG. Early enzyme release from myocardial cells is not due to irreversible cell damage. J Mol Cell Cardiol. 1984;16:185–8.
   Google Scholar
• Sommers HM, Jennings RB. Experimental acute myocardial infarction:Histologic and histochemical studies of early myo-cardial infarcts induced by temporary or permanent occlusion of a coronary artery. Lab Invest. 1964;13:149–54.
   Google Scholar
• Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, . Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001;103:2780–3.
   PubMed Web of Science ®Google Scholar
• Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, . Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury:Insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111:1027–32.
   PubMed Web of Science ®Google Scholar
• Vikenes K, Westby J, Matre K, Kuiper KKJ, Farstad M, Nor-drehaug JE. Release of cardiac Troponin I after temporally graded acute coronary ischemia with electrocardiographic ST depression. Int J Cardiology. 2002;85:243–51.
   PubMed Web of Science ®Google Scholar
• Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research:Time for a reassessment? J Am Coll Cardiol. 1999;34:618–20.
   PubMed Web of Science ®Google Scholar